AIM IMMUNOTECH Trademark

Trademark Overview


On Wednesday, September 4, 2019, a trademark application was filed for AIM IMMUNOTECH with the United States Patent and Trademark Office. The USPTO has given the AIM IMMUNOTECH trademark a serial number of 88604388. The federal status of this trademark filing is REGISTERED as of Tuesday, July 30, 2024. This trademark is owned by AIM ImmunoTech Inc.. The AIM IMMUNOTECH trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Intravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS; intravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS; intravenous solution for use in the treatment of injuries resulting from surgery, thermal accidents or burns; Interferons; Parenterally administered interferon for use in treating viral diseases, immunological disorders and cancer; Pharmaceutical products, namely, pharmaceutical preparations for treatment of viral and infectious diseases, cancer, immune disorders and ME/CFS; intranasal solutions for use as a vaccine adjuvant, all of the foregoing primarily available by prescription

Pharmaceutical research and development; Pharmaceutical research and development of drugs for the treatment of cancers, viral diseases, immunological disorders and ME/CFS
aim immunotech

General Information


Serial Number88604388
Word MarkAIM IMMUNOTECH
Filing DateWednesday, September 4, 2019
Status700 - REGISTERED
Status DateTuesday, July 30, 2024
Registration Number7463637
Registration DateTuesday, July 30, 2024
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 7, 2020

Trademark Statements


Description of MarkThe mark consists of a design of two curves with four horizontal lines between them, with the words "AIM ImmunoTech" to the right of the design and the word "AIM" above the word "ImmunoTech".
Goods and ServicesIntravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS; intravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS; intravenous solution for use in the treatment of injuries resulting from surgery, thermal accidents or burns; Interferons; Parenterally administered interferon for use in treating viral diseases, immunological disorders and cancer; Pharmaceutical products, namely, pharmaceutical preparations for treatment of viral and infectious diseases, cancer, immune disorders and ME/CFS; intranasal solutions for use as a vaccine adjuvant, all of the foregoing primarily available by prescription
Pseudo MarkAIM IMMUNO TECH
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesPharmaceutical research and development; Pharmaceutical research and development of drugs for the treatment of cancers, viral diseases, immunological disorders and ME/CFS

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 16, 2019
Primary Code005
First Use Anywhere DateWednesday, June 7, 2023
First Use In Commerce DateWednesday, June 7, 2023

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, September 16, 2019
Primary Code042
First Use Anywhere DateSaturday, August 31, 2019
First Use In Commerce DateSaturday, August 31, 2019

Trademark Owner History


Party NameAIM ImmunoTech Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressOcala, FL 34473

Party NameAIM ImmunoTech Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressOcala, FL 34473

Party NameAIM ImmunoTech Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressOcala, FL 34473

Trademark Events


Event DateEvent Description
Friday, November 22, 2019ASSIGNED TO EXAMINER
Saturday, September 7, 2019NEW APPLICATION ENTERED
Monday, September 16, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 17, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, December 3, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 18, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 7, 2020PUBLISHED FOR OPPOSITION
Tuesday, January 7, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, January 9, 2020EXTENSION OF TIME TO OPPOSE RECEIVED
Monday, July 6, 2020OPPOSITION INSTITUTED NO. 999999
Thursday, July 23, 2020ASSIGNED TO EXAMINER
Wednesday, September 22, 2021OPPOSITION TERMINATED NO. 999999
Wednesday, September 22, 2021OPPOSITION DISMISSED NO. 999999
Wednesday, September 22, 2021TTAB RELEASE CASE TO TRADEMARKS
Tuesday, November 2, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, May 2, 2022SOU TEAS EXTENSION RECEIVED
Monday, May 2, 2022SOU EXTENSION 1 FILED
Monday, May 2, 2022SOU EXTENSION 1 GRANTED
Wednesday, May 4, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 2, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, November 2, 2022SOU EXTENSION 2 FILED
Wednesday, November 2, 2022SOU EXTENSION 2 GRANTED
Friday, November 4, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 2, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, May 2, 2023SOU EXTENSION 3 FILED
Tuesday, May 2, 2023SOU EXTENSION 3 GRANTED
Thursday, May 4, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 23, 2023TEAS STATEMENT OF USE RECEIVED
Friday, June 23, 2023USE AMENDMENT FILED
Wednesday, July 19, 2023STATEMENT OF USE PROCESSING COMPLETE
Wednesday, July 19, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, February 9, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 9, 2023SU - NON-FINAL ACTION - WRITTEN
Wednesday, August 9, 2023NON-FINAL ACTION E-MAILED
Wednesday, August 9, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, November 9, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Thursday, November 9, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Friday, February 9, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, June 21, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, June 21, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, June 18, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 18, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 18, 2024ASSIGNED TO LIE
Tuesday, July 30, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, July 30, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED